LOBULAR BREAST CARCINOMA IN SITU
Clinical trials for LOBULAR BREAST CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new LOBULAR BREAST CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for LOBULAR BREAST CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation schedule aims to cut arm swelling in breast cancer patients
Disease control OngoingThis study tested a shorter course of radiation (hypofractionation) to the breast and nearby lymph nodes in 137 women with node-positive breast cancer. The goal was to see if this approach reduces long-term side effects like arm swelling (lymphedema) while still controlling cance…
Matched conditions: LOBULAR BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Diabetes drug metformin tested as breast cancer shield
Prevention OngoingThis study tests whether metformin, a common diabetes drug, can prevent breast cancer in women at high risk. Participants take metformin or a placebo for 12 months to see if it reduces abnormal cell growth in breast tissue. The goal is to find a safe, affordable way to lower canc…
Matched conditions: LOBULAR BREAST CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated May 17, 2026 10:26 UTC
-
New decision tools help High-Risk women choose cancer prevention wisely
Knowledge-focused OngoingThis study tests online decision-support tools for women with atypical hyperplasia or lobular carcinoma in situ, conditions that raise breast cancer risk. About 412 women and their doctors will use these tools to help make informed choices about chemoprevention (medication to low…
Matched conditions: LOBULAR BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: SWOG Cancer Research Network • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC